KevinFloydFolkersMD

PubMed

• 37 citations
  Treatment of hypertrophic cardiomyopathy with coenzyme Q10
  Peter H. Langsjoen, Alena M. Langsjoen, Richard A. Willis, Karl Folkers> ;Molecular Aspects of Medicine. 1997 Jan 1
• 21 citations
  Isolated diastolic dysfunction of the myocardium and its response to CoQ10 treatment.
  P. H. Langsjoen, K. Folkers> ;The Clinical Investigator. 1993 Jan 1
• 16 citations
  Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant.
  Karl Folkers, Peter H. Langsjoen, Per H. Langsjoen> ;Biochemical and Biophysical Research Communications. 1992 Jan 15
• 73 citations
  Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy
  Per H. Langsjoen, Peter H. Langsjoen, Karl A. Folkers> ;The American Journal of Cardiology. 1990 Feb 15
• 17 citations
  A Six-Year Clinical Study of Therapy of Cardiomyopathy With Coenzyme Q10
  Per H. Langsjoen, Folkers K> ;International Journal of Tissue Reactions. 1990 Jan 1
• The effect of ethanol and/or food restriction on coenzyme Q in liver in rats.
  Willis, R. A., Anthony, M., Loop, R., Llanes, C., Folkers, K.> ;Mol Aspects Med. 1997
• Could coenzyme Q10 affect hemostasis by inhibiting platelet vitronectin (CD51/CD61) receptor?
  Serebruany, V. L., Gurbel, P. A., Ordoñez, J. V., Herzog, W. R., Rohde, M., Mortensen, S. A., Folkers, K.> ;Mol Aspects Med. 1997
• Activities of vitamin Q10 in animal models and a serious deficiency in patients with cancer.
  Folkers, K., Osterborg, A., Nylander, M., Morita, M., Mellstedt, H.> ;Biochem Biophys Res Commun. 1997 May 19
• Dietary coenzyme Q10 supplementation alters platelet size and inhibits human vitronectin (CD51/CD61) receptor expression.
  Serebruany, V. L., Ordonez, J. V., Herzog, W. R., Rohde, M., Mortensen, S. A., Folkers, K., Gurbel, P. A.> ;J Cardiovasc Pharmacol. 1997 Jan
• Hemostatic changes after dietary coenzyme Q10 supplementation in swine.
  Serebruany, V. L., Herzog, W. R., Atamas, S. P., Gurbel, P. A., Rohde, M., Mortensen, S. A., Folkers, K.> ;J Cardiovasc Pharmacol. 1996 Aug
• Relevance of the biosynthesis of coenzyme Q10 and of the four bases of DNA as a rationale for the molecular causes of cancer and a therapy.
  Folkers, K.> ;Biochem Biophys Res Commun. 1996 Jul 16
• The effect of oral coenzyme Q10 on the exercise tolerance of middle-aged, untrained men.
  Porter, D. A., Costill, D. L., Zachwieja, J. J., Krzeminski, K., Fink, W. J., Wagner, E., Folkers, K.> ;Int J Sports Med. 1995 Oct
• The activities of coenzyme Q10 and vitamin B6 for immune responses.
  Folkers, K., Morita, M., McRee, J.> ;Biochem Biophys Res Commun. 1993 May 28
• Survival of cancer patients on therapy with coenzyme Q10.
  Folkers, K., Brown, R., Judy, W. V., Morita, M.> ;Biochem Biophys Res Commun. 1993 Apr 15
• A new method to determine the level of coenzyme Q10 in one drop of human blood for biomedical research.
  Morita, M., Folkers, K.> ;Biochem Biophys Res Commun. 1993 Mar 31
• Synthesis and bioassay of LHRH-antagonists with N-Ac-D-O-phenyltyrosine and N-Ac-D-3-(2-dibenzofuranyl)alanine in position 1.
  Ljungqvist, A., Bowers, C. Y., Folkers, K.> ;Int J Pept Protein Res. 1993 May
• Ubiquinone and alpha-tocopherol in plasma; means of translocation or depot.
  Karlsson, J., Diamant, B., Theorell, H., Folkers, K.> ;Clin Investig. 1993
• Heart muscle ubiquinone and plasma antioxidants following cardiac transplantation.
  Karlsson, J., Liska, J., Gunnes, S., Koul, B., Semb, B., Aström, H., Diamant, B., Folkers, K.> ;Clin Investig. 1993
• Heart failure is a dominant deficiency of coenzyme Q10 and challenges for future clinical research on CoQ10.
  Folkers, K.> ;Clin Investig. 1993
• Myocardial preservation by therapy with coenzyme Q10 during heart surgery.
  Judy, W. V., Stogsdill, W. W., Folkers, K.> ;Clin Investig. 1993
• Mitochondrial myopathy with anemia, cardiomyopathy, and lactic acidosis: a distinct late onset mitochondrial disorder.
  Van Hove, J. L., Shanske, S., Ciacci, F., Ballinger, S., Shoffner, J. S., Wallace, D. C., Hanioka, T., Folkers, K., Bossen, E. H., Kussin, P. S.> ;Am J Med Genet. 1994 Jun 1
• Novel, potent luteinizing hormone-releasing hormone antagonists with improved solubility in water.
  Janecka, A., Janecki, T., Shan, S. M., Bowers, C., Folkers, K.> ;J Med Chem. 1994 Jul 8
• New, highly active antagonists of LHRH with acylated lysine and p-aminophenylalanine in positions 5 and 6.
  Janecka, A., Janecki, T., Bowers, C. Y., Folkers, K.> ;Int J Pept Protein Res. 1994 Jul
• Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10.
  Lockwood, K., Moesgaard, S., Folkers, K.> ;Biochem Biophys Res Commun. 1994 Mar 30
• Treatment of essential hypertension with coenzyme Q10.
  Langsjoen, P., Langsjoen, P., Willis, R., Folkers, K.> ;Mol Aspects Med. 1994
• Join now to see all